Please login to the form below

Not currently logged in
Email:
Password:

multidrug resistant infections

This page shows the latest multidrug resistant infections news and features for those working in and with pharma, biotech and healthcare.

FDA green lights study of phage-based drug for resistant infections

FDA green lights study of phage-based drug for resistant infections

Possible alternative to conventional antibiotics. With multidrug resistant (MDR) infections on the rise worldwide, researchers have started looking at using bacteriophages – viruses that only infect bacteria – as an alternative to a ... cocktails for

Latest news

  • Pfizer launches antibiotic resistance surveillance website Pfizer launches antibiotic resistance surveillance website

    Dr Freda Lewis-Hall, Pfizer’s chief medical officer, said: “An important aspect for physicians when treating patients is knowledge; knowledge of where certain resistant bacterial infections tend to occur and ... Meanwhile, Pfizer’s new antibiotic

  • Pfizer launches new antibiotic Zavicefta in UK and Germany Pfizer launches new antibiotic Zavicefta in UK and Germany

    Biopharmaceutical company Pfizer releases MDR antibiotic. Pfizer's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been launched in the UK and Germany, its first EU markets. ... One of the key roles for the new product is in the

  • AZ gets EU green light for new antibiotic Zavicefta AZ gets EU green light for new antibiotic Zavicefta

    EMA approves combination drug for treatment of multidrug resistant infections. AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in the EU. ... Some CRE infections are resistant to all

  • Merck starts pivotal trials of new antibiotic combination Merck starts pivotal trials of new antibiotic combination

    Beta-lactamase inhibitor relebactam is a welcome addition to the late-stage antibiotics pipeline, which remains fairly sparse despite high levels of concern worldwide about multidrug resistant (MDR) infections. ... imipenem), a broad-spectrum carbapenem

  • CHMP backs AZ's 'superbug' antibiotic product CHMP backs AZ's 'superbug' antibiotic product

    Zavicefta recommended for European approval. AstraZeneca is months away from introducing Zavicefta, its new antibiotic product for multidrug resistant (MDR) infections, in the EU. ... Some CRE infections are resistant to all known antibiotics and

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics